Skip to main content
. 2009 Jul;68(1):61–76. doi: 10.1111/j.1365-2125.2009.03401.x

Figure 4.

Figure 4

Relationship between body mass index and parameters for omalizumab and IgE, across the five studies. ETA for the parameters is the random variability between patients that is not explained by the bodyweight and baseline IgE covariates included in the model. The line through the centre is a local regression calculated in R with the LOESS function, with a span of 0.25